Midazolam is a water-soluble benzodiazepine imide that has been used in recent years to manage status epilepticus (SE). We describe four patients with SE refractory to conventional treatment, whose seizures were controlled with midazolam administered intramuscularly in two cases and intravenously in the remaining two. Given the pharmacokinetic traits of this drug, the intramuscular route offers great advantages. Midazolam also produces fewer side effects than do other benzodiazepines, suggesting the possibility of its use as a first line treatment for SE and frequent epileptic seizures
Status epilepticus (SE) refractory to benzodiazepines and other antiepileptic agents is managed with...
Midazolam is a short-acting water soluble benzodiazepine that has been used with an increasing frequ...
Status Epilepticus (SE) is a neurologic emergency associated with high morbidity and mortality. The...
Introduction: Status epilepticus (SE) is a common neurological and medical emergency. It has high mo...
Objective: To study the clinical efficacy of midazolam in the treatment of 224 patients with status ...
Status epilepticus (SE) requires rapid identification of its cause and urgent pharmacological treatm...
The pharmacokinetics of midazolam, a water soluble 1,4-benzodiazepine, has been studied in 12 patien...
Midazolam is a recently developed water-soluble benzodiazepine that shares anxiolytic, muscle relaxa...
In convulsive status epilepticus (SE), achieving seizure control within the first 1-2 hours after on...
Status epilepticus (SE) is a medical emergency associated with significant morbidity and mortality. ...
Abstract published with permission. Epilepsy is a common neurological condition causing seizures or ...
Objective The aim of this study was to evaluate the efficacy and safety of intramuscular midazolam i...
Objective: We sought to evaluate the efficacy and tolerability of intranasal midazolam (in‐MDZ) as f...
People with a learning disability are often disadvantaged due to the nature of their disability. Up ...
ObjectiveTo examine the use of benzodiazepines and the association between low benzodiazepine dose, ...
Status epilepticus (SE) refractory to benzodiazepines and other antiepileptic agents is managed with...
Midazolam is a short-acting water soluble benzodiazepine that has been used with an increasing frequ...
Status Epilepticus (SE) is a neurologic emergency associated with high morbidity and mortality. The...
Introduction: Status epilepticus (SE) is a common neurological and medical emergency. It has high mo...
Objective: To study the clinical efficacy of midazolam in the treatment of 224 patients with status ...
Status epilepticus (SE) requires rapid identification of its cause and urgent pharmacological treatm...
The pharmacokinetics of midazolam, a water soluble 1,4-benzodiazepine, has been studied in 12 patien...
Midazolam is a recently developed water-soluble benzodiazepine that shares anxiolytic, muscle relaxa...
In convulsive status epilepticus (SE), achieving seizure control within the first 1-2 hours after on...
Status epilepticus (SE) is a medical emergency associated with significant morbidity and mortality. ...
Abstract published with permission. Epilepsy is a common neurological condition causing seizures or ...
Objective The aim of this study was to evaluate the efficacy and safety of intramuscular midazolam i...
Objective: We sought to evaluate the efficacy and tolerability of intranasal midazolam (in‐MDZ) as f...
People with a learning disability are often disadvantaged due to the nature of their disability. Up ...
ObjectiveTo examine the use of benzodiazepines and the association between low benzodiazepine dose, ...
Status epilepticus (SE) refractory to benzodiazepines and other antiepileptic agents is managed with...
Midazolam is a short-acting water soluble benzodiazepine that has been used with an increasing frequ...
Status Epilepticus (SE) is a neurologic emergency associated with high morbidity and mortality. The...